Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “Prevention of Nausea and Vomiting Caused by Highly Emetogenic Chemotherapy”

4 trials

Showing 4 of 4 results

Early research (Phase 1)Study completedNCT05465681
What this trial is testing

Study of HR20013 for Injection in Patients With Malignant Solid Tumors

Who this might be right for
Prevention of Nausea and Vomiting Caused by Highly Emetogenic Chemotherapy
Fujian Shengdi Pharmaceutical Co., Ltd. 24
Large-scale testing (Phase 3)Study completedNCT00431236
What this trial is testing

The Drug Casopitant for the Prevention of Nausea Caused By Cisplatin-Based Highly Emetogenic Chemotherapy

Who this might be right for
Nausea and Vomiting, Chemotherapy-Induced
GlaxoSmithKline 810
Large-scale testing (Phase 3)WithdrawnNCT00891761
What this trial is testing

IV Casopitant for the Prevention of Nausea and Vomiting Caused By Cisplatin-Based Highly Emetogenic Chemotherapy

Who this might be right for
CancerChemotherapy-Induced Nausea and VomitingNausea and Vomiting+1 more
GlaxoSmithKline
Large-scale testing (Phase 3)Study completedNCT05509634
What this trial is testing

Clinical Study of HR20013 for Injection in Patients With Malignant Solid Tumors

Who this might be right for
Prevention of Nausea and Vomiting Caused by Highly Emetogenic Chemotherapy
Fujian Shengdi Pharmaceutical Co., Ltd. 754

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation